ACI Joins Coalition in Opposition to the Pelosi Drug Tax Pan

Today, ACI joined 70 other organizations in opposition to the prescription drug pricing bill offered by House Speaker Nancy Pelosi. The bill would impose excise taxes up to 95% on hundreds of prescription medicines. You can read the coalition letter online. 10-15-19 Coalition Letter Opposed to Pelosi Drug Tax Plan

Study: Addressing Privacy and Security Concerns with Distributed Tech without Impeding Innovation

In May 2018, the Federal Bureau of Investigation (FBI) published a warning notifying that Russian computer hackers had compromised hundreds of thousands of home and office routers and could collect user information or shut down network traffic. The Bureau then urged the owners of several brands of routers to turn them off and on again, and […]

ACI Joins a Coalition Calling on the FDA to Release Its Data on Teen Vaping

Today, ACI joins a 14 nonprofit organizations representing both consumers and taxpayers in sending a letter to the Acting Commissioner, Norman Sharpless. This letter calls for the FDA to release its data from the 2019 National Youth Tobacco Survey before moving any further with the proposed ban on vaping products. The public deserves to know […]

ACI Applauds the Court Decision to Uphold Rules for an Open and Free Internet

The following statement can be attributed to Steve Pociask, President of the American Consumer Institute, regarding today’s decision by the D.C. Circuit Court of Appeals on the Mozilla v. FCC case: “Today, the D.C. Circuit Court upheld the FCC’s latest order to keep an open and free Internet, instead of reverting back to onerous 1930’s […]

Capital Hill Event: Drug Pricing Policy Prescriptions for 2020

On September 25, 2019, the American Consumer Institute held a policy briefing called “Pricing Policy Prescriptions for 2020: The Good, The Bad, and The Ugly.” The event included guest speaker John Fund, along with the following policy experts: Krisztina Pusok, Director of Policy and Research at the American Consumer Institute (moderating); Robert Graboyes is a Senior […]

Drug Pricing Policy Prescriptions for 2020: The Good, The Bad, and The Ugly — September 25, 2019

Senate Russell Office Building Featured Keynote Speaker: John Fund Topic: Escalating drug prices are generating a fierce political and policy debate. Join the American Consumer Institute on September 25th for a distinguished panel of experts who will discuss recent proposals put forth in Congress and the White House to address increasing prescription drug costs. Hear […]

Coalition Calls for Increased Generic Drug Competition

While the Lower Health Care Costs Act is intended to increase competition and patient access to lower cost medicines, section 205 of the bill needs to address FDA concerns about the “parking” of generic applications. We believe generic manufacturers need to launch new medications into the market as soon as possible after approval. However, as […]